These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25277182)

  • 21. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
    Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter.
    Deng J; Liang H; Dong Q; Hou Y; Xie X; Yu J; Fan D; Hao X
    Open Biol; 2014 Jul; 4(7):. PubMed ID: 25008234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.
    Shigeyasu K; Nagasaka T; Mori Y; Yokomichi N; Kawai T; Fuji T; Kimura K; Umeda Y; Kagawa S; Goel A; Fujiwara T
    PLoS One; 2015; 10(6):e0130409. PubMed ID: 26121593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia.
    Hütter G; Kaiser M; Neumann M; Mossner M; Nowak D; Baldus CD; Gökbuget N; Hoelzer D; Thiel E; Hofmann WK
    Leuk Res; 2011 May; 35(5):614-9. PubMed ID: 21156323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylated TIMP-3 DNA in body fluids is an independent prognostic factor for gastric cancer.
    Yu JL; Lv P; Han J; Zhu X; Hong LL; Zhu WY; Wang XB; Wu YC; Li P; Ling ZQ
    Arch Pathol Lab Med; 2014 Nov; 138(11):1466-73. PubMed ID: 25357107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter CpG island hypermethylation and down regulation of XRCC1 gene can augment in the gastric carcinogenesis events.
    Nissar B; Kadla SA; Wani KA; Shah IA; Ganai BA
    Mol Biol Rep; 2021 Jan; 48(1):405-412. PubMed ID: 33394233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis.
    Hosoya K; Yamashita S; Ando T; Nakajima T; Itoh F; Ushijima T
    Cancer Lett; 2009 Nov; 285(2):182-9. PubMed ID: 19527921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypomethylation-activated cancer-testis gene LIN28B promotes cell proliferation and metastasis in gastric cancer.
    Xu J; Zhou Y; Yang J; Gu Y; Zhang E; Yuan W; Wang C; Jin G; Ma H; Hu Z
    Gene; 2022 Mar; 813():146115. PubMed ID: 34902508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.
    Han F; Sun LP; Liu S; Xu Q; Liang QY; Zhang Z; Cao HC; Yu J; Fan DM; Nie YZ; Wu KC; Yuan Y
    Oncotarget; 2016 Apr; 7(17):24800-9. PubMed ID: 27050149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer.
    Wang N; Sui F; Ma J; Su X; Liu J; Yao D; Shi B; Hou P; Yang Q
    Arch Med Res; 2016 May; 47(4):285-92. PubMed ID: 27664488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability.
    Kang GH; Lee S; Shim YH; Kim JC; Ro JY
    Pathol Int; 2002 Dec; 52(12):764-8. PubMed ID: 12588445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
    Li T; Chen X; Gu M; Deng A; Qian C
    Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
    Shin SH; Park SY; Kang GH
    Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
    Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
    Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower LINE-1 methylation is associated with promoter hypermethylation and distinct molecular features in gastric cancer.
    Tahara S; Tahara T; Horiguchi N; Okubo M; Terada T; Yoshida D; Funasaka K; Nakagawa Y; Shibata T; Tsukamoto T; Ohmiya N
    Epigenomics; 2019 Nov; 11(15):1651-1659. PubMed ID: 31701771
    [No Abstract]   [Full Text] [Related]  

  • 37. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
    Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
    Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
    Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
    Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
    Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers.
    Palmisano WA; Crume KP; Grimes MJ; Winters SA; Toyota M; Esteller M; Joste N; Baylin SB; Belinsky SA
    Cancer Res; 2003 Aug; 63(15):4620-5. PubMed ID: 12907641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.